Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
<p><strong>BACKGROUND</strong></p> <p>Salmonella Typhi is a major cause of fever in children in low- and middle-income countries. A typhoid conjugate vaccine (TCV) that was recently prequalified by the World Health Organization was shown to be efficacious in a human cha...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
Massachusetts Medical Society
2019
|